Stage
Line of Credit | AliveTotal Raised
$215MLast Raised
$140M | 6 yrs agoAbout Iroko Pharmaceuticals
Iroko is a global specialty pharmaceutical company, based in Philadelphia, dedicated to advancing the science of analgesia. The company develops and globally commercializes pharmaceutical products. In addition to the Iroko products that are marketed worldwide, the company has a robust pipeline of investigational lower dose NSAID products being developed using iCeutica Pty proprietary SoluMatrix Fine Particle Technology.
Iroko Pharmaceuticals Headquarter Location
150 Rouse Blvd
Philadelphia, Pennsylvania, 19112,
United States
267-546-3003
Latest Iroko Pharmaceuticals News
Dec 4, 2020
Data Bridge Market research released a new market study on Patent ductus arteriosus treatment with 100+ market data Tables, Pie Chart, Graphs & Figures spread through Pages and easy to understand detailed analysis In Patent ductus arteriosus treatment research report also directs the manufacturer about planning of advertising and sales promotion efforts and makes it more effective. The report consists of all the detailed profiles for the Patent ductus arteriosus treatment major manufactu...
Expert Collections containing Iroko Pharmaceuticals
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Iroko Pharmaceuticals is included in 1 Expert Collection, including Biopharma Tech.
Biopharma Tech
15,532 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
